Login / Signup

Response to: 'Correspondence to 'Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases'' by Wu et al.

José Luís PablosMaría GalindoRicardo Blanco-AlonsoJosé María Álvaro-Gracia
Published in: Annals of the rheumatic diseases (2020)
Keyphrases
  • coronavirus disease
  • sars cov
  • risk factors
  • multiple sclerosis
  • healthcare
  • oxidative stress
  • acute care
  • adverse drug
  • drug induced
  • real time pcr